Results 151 to 160 of about 330,051 (347)

Appetite for sugar and fat in the thiamine deficient rat [PDF]

, 1965
Harold R. Behrman, Owen Maller
openalex   +1 more source

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

Gut, 2017
Zhuang Li, C. Yi, S. Katiraei, S. Kooijman, E. Zhou, Chih Kit Chung, Yuanqing Gao, J. K. van den Heuvel, O. Meijer, J. F. Berbée, M. Heijink, M. Giera, K. Willems van Dijk, A. Groen, P. Rensen, Yanan Wang   +15 more
semanticscholar   +1 more source

First‐in‐Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN‐3143, a Novel Inhibitor of Mono‐Adenosine Diphosphate Ribosyltransferase‐PARP14

Clinical Pharmacology in Drug Development, EarlyView.
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek, Alexandra Cole, Viviana Bozón, Erika Manyak, Jonathan Novak, Barbara Yang, Briohny A. Johnston, Sudha Parasuraman, Kushal J. Paneliya, Virna Schuck   +9 more
wiley   +1 more source

The effects of qualitative and quantitative variation in the US on individual components of Pavlovian appetitive conditioned behavior in rats [PDF]

, 1979
Peter C. Holland
openalex   +1 more source

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies

Clinical Pharmacology in Drug Development, EarlyView.
Abstract This study (NCT04537715) investigated itraconazole (strong cytochrome P450 [CYP] 3A inhibitor) and rifampin (strong CYP3A inducer) on tazemetostat pharmacokinetics. In Part 1, patients received tazemetostat 400 mg orally on Days 1, 15, and 36, and 400 mg twice daily on Days 3‐14 and Days 21‐35.
Yingxue Chen, Renli Teng, Attila Szanto, Apoorva Kapopara, Rajat Bannerji, Julien Ogier, Devalingam Mahalingam   +6 more
wiley   +1 more source

Demonstration of a Kamin-like effect after appetitive training [PDF]

, 1971
Taishwarnauth Tribhowan, William B. Rucker, Colin G. McDiarmid   +2 more
openalex   +1 more source

Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study

Cancer Communications, EarlyView.
Niels Heersche, Daan A. C. Lanser, Esther Oomen‐de Hoop, Attila Içli, Peter de Bruijn, Marthe S. Paats, Elisabeth F. C. van Rossum, Stijn L. W. Koolen, Ron H. N. van Schaik, Anne‐Marie C. Dingemans, G. D. Marijn Veerman, Ron H. J. Mathijssen   +11 more
wiley   +1 more source

A Randomized Thorough QT Trial Using Concentration‐QT Analysis to Evaluate the Effects of Centanafadine on Cardiac Repolarization

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Centanafadine is a norepinephrine/dopamine/serotonin reuptake inhibitor in development for treatment of attention‐deficit/hyperactivity disorder. This double‐blind, placebo‐ and moxifloxacin‐controlled, 3‐period crossover trial evaluated the effects of centanafadine (EB‐1020) and its metabolite (EB‐10601) on cardiac repolarization in 30 ...
Osman S. Turkoglu, Xiaofeng Wang, Jennifer Repella‐Gordon, Susan E. Shoaf   +3 more
wiley   +1 more source

ACBP is an appetite stimulator across phylogenetic barriers

Cell Stress, 2020
Frank Madeo, Nektarios Tavernarakis, José M. Bravo-San Pedro, Guido Kroemer   +3 more
doaj   +1 more source

Pavlovian aversive to instrumental appetitive transfer: Evidence for across-reinforcement blocking effects [PDF]

, 1977
H. Fowler, Joel H. Goodman, Mary Lou Zanich   +2 more
openalex   +1 more source